ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OPK vs OMER // REVENUE GROWTH (YOY)

OPKO Health Inc. (NASDAQ) VS. Omeros Corporation (NASDAQ) • 15-METRIC TALLY: OPK 3 — OMER 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OPK VS. OMER) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OPK OMER SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 33.90% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -10.20% -35.00% +24.80 OPK /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -14.41% -8.47% -5.94 OMER /fcf-yield <GO>
Operating Margin -19.30% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) ACTIVE -14.90% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 1/9 +3.00 OPK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 64.0 48.9 +15.10 OPK /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.28B $1.29B -$7.0M OMER /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OPK REV OMER REV OPK GROSS % OMER GROSS % OPK FCF OMER FCF
FY 2025 $606.9M $343.8M 33.9% — -$178.5M -$116.2M
FY 2024 $713.1M $467.5M 30.6% — -$183.5M -$149.0M
FY 2023 $863.5M — — — -$28.2M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OPK // BETA —
OMER // BETA —